Finance

Lists
2096:HKG
Simcere Pharmaceutical Group Ltd
၁၁.၀၂ HK$
+၁.၇၅%
(+၀.၁၉) 1D
အောက် ၁၆, GMT+၈ ၁၆:၀၈:၁၄  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 2096...
Open
၁၀.၈၅ HK$
High
၁၁.၂၉ HK$
Low
၁၀.၈၅ HK$
Mkt. cap
ဋေ ၂.၈၃ ထ
Avg. vol.
၄.၀၂ သန်း
Volume
၅.၈၀ သန်း
Dividend
၁.၈၈%
Quarterly dividend
၀.၀၅ HK$
Ex-dividend date
၂၀၂၅ ဇွန် ၁၈
P/E ratio
၁၆.၅၄
52-wk high
၁၄.၃၈ HK$
52-wk low
၉.၀၇ HK$
EPS
၀.၆၇ HK$
Shares outstanding
၂၅၆.၈၂ ဋေ
No. of employees
၇ ထောင်
Open
၁၀.၈၅ HK$
High
၁၁.၂၉ HK$
Low
၁၀.၈၅ HK$
Mkt. cap
ဋေ ၂.၈၃ ထ
Avg. vol.
၄.၀၂ သန်း
Volume
၅.၈၀ သန်း
Dividend
၁.၈၈%
Quarterly dividend
၀.၀၅ HK$
Ex-dividend date
၂၀၂၅ ဇွန် ၁၈
P/E ratio
၁၆.၅၄
52-wk high
၁၄.၃၈ HK$
52-wk low
၉.၀၇ HK$
EPS
၀.၆၇ HK$
Shares outstanding
၂၅၆.၈၂ ဋေ
No. of employees
၇ ထောင်
News stories
From web sources and news partners
TheStreet
TheStreet
·
ပြီးခဲ့သည့် ၃၆ မိနစ်
Sam Stovall’s S&P 500 outlook offers hope for 2027
Yahoo Finance
Yahoo Finance
·
ပြီးခဲ့သည့် ၁ နာရီ
Nasdaq Stocks Could Crash 30% If This Happens, Experts Warn
Profile
Simcere Pharmaceutical Group or Simcere Pharmaceutical is a manufacturer and supplier of branded generic pharmaceuticals in the Chinese market. Its focus is to introduce generic and pharmaceutical products for the treatment of diseases with high incidence and/or mortality rate. The company has introduced a generic anti-stroke medication under the brand name, Bicun, and an anti-cancer medication under the brand name, Endu. Its products include antibiotics, anti-stroke medications, anti-inflammatory drugs, anti-cancer medications and other medicines. In addition, it has obtained approvals from the China State Food and Drug Administration to manufacture and sell over 210 other products. Wikipedia
About Simcere Pharmaceutical Group Ltd
CEORen Jinsheng
Employees၇.၀၆ ထောင်
Founded၁၉၉၅
HeadquartersNanjing, Jiangsu, တရုတ်
Sector-
Previous reports
Loading Previous Earnings...
Revenue
Net income
All values in CNY
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
၂၀၇.၃၂ ဋေ
၂၀၇.၃၂ ဋေ
၂၂၉.၀၁ ဋေ
၂၂၉.၀၁ ဋေ
Cost of goods sold
၃၆.၅၂ ကုဋေ
၃၆.၅၂ ကုဋေ
၃၈.၂၆ ကုဋေ
၃၈.၂၆ ကုဋေ
Cost of revenue
၃၆.၅၂ ကုဋေ
၃၆.၅၂ ကုဋေ
၃၈.၂၆ ကုဋေ
၃၈.၂၆ ကုဋေ
Research and development expenses
၄၆.၅၃ ကုဋေ
၄၆.၅၃ ကုဋေ
၄၁.၂၅ ကုဋေ
၄၁.၂၅ ကုဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၉၄.၉၅ ကုဋေ
၉၄.၉၅ ကုဋေ
၁၀၁.၄၉ ဋေ
၁၀၁.၄၉ ဋေ
Operating expense
၁၃၅.၆၇ ဋေ
၁၃၅.၆၇ ဋေ
၁၃၈.၆၅ ဋေ
၁၃၈.၆၅ ဋေ
Total operating expenses
၁၇၂.၁၉ ဋေ
၁၇၂.၁၉ ဋေ
၁၇၆.၉၁ ဋေ
၁၇၆.၉၁ ဋေ
Operating income
၃၅.၁၃ ကုဋေ
၃၅.၁၃ ကုဋေ
၅၂.၁၀ ကုဋေ
၅၂.၁၀ ကုဋေ
Other non operating income
-
-
-
-
EBT including unusual items
၄၂.၅၉ ကုဋေ
၄၂.၅၉ ကုဋေ
၄၈.၃၄ ကုဋေ
၄၈.၃၄ ကုဋေ
EBT excluding unusual items
၃၄.၈၉ ကုဋေ
၃၄.၈၉ ကုဋေ
၅၃.၁၆ ကုဋေ
၅၃.၁၆ ကုဋေ
Income tax expense
၅.၅၇ ကုဋေ
၅.၅၇ ကုဋေ
၇.၀၁ ကုဋေ
၇.၀၁ ကုဋေ
Effective tax rate
၁၃.၀၈%
၁၃.၀၈%
၁၄.၅၀%
၁၄.၅၀%
Other operating expenses
-၅.၆၃ ကုဋေ
-၅.၆၃ ကုဋေ
-၄.၂၉ ကုဋေ
-၄.၂၉ ကုဋေ
Net income
၃၇.၀၂ ကုဋေ
၃၇.၀၂ ကုဋေ
၄၁.၄၄ ကုဋေ
၄၁.၄၄ ကုဋေ
Net profit margin
၁၇.၈၆%
၁၇.၈၆%
၁၈.၀၉%
၁၈.၀၉%
Earnings per share
-
-
-
-
Interest and investment income
၁.၄၆ ကုဋေ
၁.၄၆ ကုဋေ
၂.၄၂ ကုဋေ
၂.၄၂ ကုဋေ
Interest expense
-၂.၃၆ ကုဋေ
-၂.၃၆ ကုဋေ
-၂.၄၆ ကုဋေ
-၂.၄၆ ကုဋေ
Net interest expenses
-၉.၀၃ သန်း
-၉.၀၃ သန်း
-၄.၁၆ သိန်း
-၄.၁၆ သိန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
၄၄.၉၇ ကုဋေ
၄၄.၉၇ ကုဋေ
၆၀.၆၀ ကုဋေ
၆၀.၆၀ ကုဋေ
Gain or loss from assets sale
-၁.၁၆ သိန်း
-၁.၁၆ သိန်း
-
-
AI content may include mistakes. Learn more
Google အက်ပ်များ